Literature DB >> 6832946

Hypertension in middle-aged men. Associated factors and mortality experience.

E Holtzman, U Goldbourt, T Rosenthal, S Yaari, H N Neufeld.   

Abstract

Seven hundred and seventeen hypertensive middle-aged men (HTs) were compared with 4,438 normotensive men (NTs). The association between the prevalence of hypertension and a number of demographic, physical, biochemical and electrocardiographic characteristics was examined by multiple logistic analysis. HTs were characterized by significant elevations of pulse rate, relative weight, serum uric acid, and high-density lipoprotein-cholesterol. HTs had a higher percent of major electrocardiographic findings, such as ischemic T wave changes, ST depression and, most significantly, left-ventricular hypertrophy. They were 4.7 yr older than the NTs and were more often of Central European than of Middle Eastern descent. Mortality in HTs over a 4.5-yr period was dose-response related to casual systolic and diastolic blood pressure readings at baseline. The age-adjusted HT/NT mortality ratio was approximately 2.5:1. Cardiovascular and cerebrovascular disease accounted for 69% of the total mortality among HTs as compared with 48% among NTs. The estimated mortality fraction attributable to hypertension was 23%. This figure provides an estimate for the goal of hypertension control in the community.

Entities:  

Mesh:

Year:  1983        PMID: 6832946

Source DB:  PubMed          Journal:  Isr J Med Sci        ISSN: 0021-2180


  3 in total

1.  Multivariate prediction of total and cardiovascular mortality in an obese Polynesian population.

Authors:  D E Crews
Journal:  Am J Public Health       Date:  1989-08       Impact factor: 9.308

2.  Effects of the Israel doctors' strike on hypertension control in Ashdod.

Authors:  O A Marcovici; P E Slater; A Y Ellencweig
Journal:  Eur J Epidemiol       Date:  1987-03       Impact factor: 8.082

3.  Cigarette use among Arab Americans in the Detroit metropolitan area.

Authors:  V H Rice; A Kulwicki
Journal:  Public Health Rep       Date:  1992 Sep-Oct       Impact factor: 2.792

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.